(Q34452654)

2 August 2017

1 reference

title

Histamine dihydrochloride: inhibiting oxidants and synergising IL-2-mediated immune activation in the tumour microenvironment (English)

1 reference

2 August 2017

Agarwala SS

1

1 reference

PubMed ID

11728221

2 August 2017

Sabbagh MH

series ordinal

2

1 reference

PubMed ID

11728221

2 August 2017

language of work or name

English

0 references

publication date

1 September 2001

1 reference

Expert Opinion on Biological Therapy

2 August 2017

1 reference

2 August 2017

1

1 reference

2 August 2017

5

1 reference

2 August 2017

869-879

1 reference

Lymphocytes infiltrating human breast cancers lack K-cell activity and show low levels of NK-cell activity

2 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.5.869

Suppression of natural killing in vitro by monocytes and polymorphonuclear leukocytes: requirement for reactive metabolites of oxygen

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.5.869

Oxidative stress by tumor-derived macrophages suppresses the expression of CD3 zeta chain of T-cell receptor complex and antigen-specific T-cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.5.869

The immune system. First of two parts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.5.869

Immune interferon: a pleiotropic lymphokine with multiple effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.5.869

Switch of histamine receptor expression from H2 to H1 during differentiation of monocytes into macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.5.869

Histamine induces CD86 expression and chemokine production by human immature dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.5.869

The hematopoietic development of dendritic cells: a distinct pathway for myeloid differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.5.869

A new American Joint Committee on Cancer staging system for cutaneous melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.5.869

Temozolomide, a novel alkylating agent with activity in the central nervous system, may improve the treatment of advanced metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.5.869

The importance of tamoxifen to a cisplatin-containing regimen in the treatment of metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.5.869

Phase-II study of recombinant alpha 2-interferon in advanced malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.5.869

Dose efficacy study of two schedules of high-dose bolus administration of interleukin 2 and interferon alpha in metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.5.869

Recombinant interleukin-2 and adoptive immunotherapy alternated with dacarbazine therapy in melanoma: a National Biotherapy Study Group trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.5.869

Treatment of acute myelogenous leukemia in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.5.869

A physiologic function for p-glycoprotein (MDR-1) during the migration of dendritic cells from skin via afferent lymphatic vessels

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.5.869

Role of non-conventional natural killer cells in resistance against syngeneic tumour cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.5.869

21 January 2018

Identifiers

DOI

10.1517/14712598.1.5.869

1 reference

2 August 2017

1 reference

PubMed ID

11728221